RecruitingNCT06890078

Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Optimisation du Diagnostic de Pneumocystose Chez Les Patients Immunodéprimés

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

240 participants

Start Date

Jul 8, 2025

Study Type

OBSERVATIONAL

Conditions

Pneumocystis Immunocompromised Patients

Summary

Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biological sampling for people with immunocompromised patients and pneumocystis. The study is currently recruiting participants at 4 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.